Naturalendo Tech Co., Ltd. engages in the research, development, and commercialization of novel drugs from natural hormonal products for endocrinology applications. The company's products include EstroG-100, a proprietary standardized herbal root extract for use in the relief of hot flashes/night sweats, trouble sleeping, nervousness, depression, dizziness, tiredness, numbness on hand/foot, joint and muscle pain, formication, and vaginal dryness. It also provides Wellmune, an immune enhancer; Transdermal drug delivery system to directly deliver drug to skin; Microneedles to deliver active ingredients to dermis; other hormonal formulas comprising hormone disruptor inhibitor; and Derma A2 for the treatment of atopic dermatitis and acne. The company also exports its products worldwide. Naturalendo Tech Co., Ltd. was founded in 2001 and is headquartered in Seongnam, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $1.05 | N/A |
Market Cap | $21.56M | N/A |
Shares Outstanding | 20.48M | N/A |
Employees | 67.00 | N/A |